| Jul 2 |
Fireside Chat with Adrian Rawcliffe, Chief Executive Officer of Adaptimmune
|
| Jun 12 |
ADAP: Initiating Coverage of Adaptimmune, a Leading T-Cell Therapy Company
|
| Jun 3 |
Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise
|
| May 30 |
Adaptimmune, Galapagos to collaborate on uza-cel T-cell therapy
|
| May 30 |
Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications
|
